Hinweis-Modus ist eingeschaltet Ausschalten

HLTH - VanEck Vectors Global Healthcare Leaders ETF (AU0000102683)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen
 
(%)
AU0000102683
HLTH ISIN
Exchange Traded Funds (ETF)
Fondstyp
VanEck
Anbieter
11,69 AUD
NAV pro Aktie | 05/08/2026
08/09/2020
Startdatum
1 Wiederholungen pro Jahr
Ausschüttung von Dividenden
CEXXXU
CFI
HLTH
Ticker
Formed
Status
Equity
Investitionsobjekt
Healthcare
Sektor
Developed markets
Geographie
MarketGrader Developed Markets (ex-Australia) Health Care Index 
Benchmark
0.45 %
Gesamtkostenquote
52,11 Mio. AUD
Gesamtes Fondsvermögen | 05/08/2026
52,11 Mio. AUD
Aktien-Anlageklasse Volumen | 05/08/2026
Nein
UCITS

Rendite auf 05/08/2026, Australian S.E.

  • YTD
    -10,9 %
  • 1M
    -3,57 %
  • 3M
    -8,95 %
  • 6M
    -13,4 %
  • 1J
    -4,26 %
  • 3J
    4,5 %
  • 5J
    6,6 %
  • 10J
    -
Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum
Zum Vergleichen hinzufügen
von
zu
ADD-IN
Cbonds Add-In API
API Anleihen-Daten

Kurse (HLTH)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

100 000

Aktien

175 910

ETF & Funds

100 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In
Zugang erhalten

Kurs-Dynamik

HLTH profile

The VanEck Vectors Global Healthcare Leaders ETF is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Developed markets. The VanEck fund’s base currency is AUD and the share class was registered 08.09.2020 with unique ISIN - AU0000102683. Main exchange is Australian S.E. and ticker symbol is HLTH. The total expense ratio is 0.45%. The VanEck Vectors Global Healthcare Leaders ETF pays dividends 1 time(s) per year.

Struktur HLTH auf 05/08/2026

Struktur in Excel herunterladen
Wertpapier Wertpapier
Illumina Inc 3,24%
Illumina Inc 3,18%
Arrowhead Pharmaceuticals Inc 3,09%
Arrowhead Pharmaceuticals Inc 2,99%
West Pharmaceutical Services Inc 2,83%
West Pharmaceutical Services Inc 2,81%
Exelixis Inc 2,61%
Ypsomed Holding Ag 2,6%
Exelixis Inc 2,58%
Dexcom Inc 2,57%
Ypsomed Holding Ag 2,56%
Halozyme Therapeutics Inc 2,49%
Halozyme Therapeutics Inc 2,48%
Incyte Corp 2,47%
Incyte Corp 2,45%
Dexcom Inc 2,44%
Neurocrine Biosciences Inc 2,43%
Novo Nordisk A/S 2,38%
Neurocrine Biosciences Inc 2,36%
Argenx Se 2,35%
Argenx Se 2,29%
Novo Nordisk A/S 2,28%
Orion Oyj 2,25%
Eli Lilly & Co 2,25%
Teva Pharmaceutical Industries Ltd 2,23%
Orion Oyj 2,21%
Teva Pharmaceutical Industries Ltd 2,21%
Tenet Healthcare Corp 2,18%
Eli Lilly & Co 2,15%
Fisher & Paykel Healthcare Corp Ltd 2,12%
Bristol-Myers Squibb Co 2,12%
Amgen Inc 2,11%
Tenet Healthcare Corp 2,11%
Merck & Co Inc 2,1%
Otsuka Holdings Co Ltd 2,1%
Merck & Co Inc 2,1%
Encompass Health Corp 2,09%
Encompass Health Corp 2,09%
Fisher & Paykel Healthcare Corp Ltd 2,09%
Otsuka Holdings Co Ltd 2,06%
Bristol-Myers Squibb Co 2,04%
Alk-Abello A/S 2,03%
Amgen Inc 2,02%
Kyowa Kirin Co Ltd 2,02%
Johnson & Johnson 2,02%
Kyowa Kirin Co Ltd 2,02%
Ipsen Sa 2,01%
Johnson & Johnson 2%
Alk-Abello A/S 1,99%
Alteogen Inc 1,98%
Ipsen Sa 1,97%
Vertex Pharmaceuticals Inc 1,96%
Idexx Laboratories Inc 1,94%
Vertex Pharmaceuticals Inc 1,94%
Idexx Laboratories Inc 1,93%
Stryker Corp 1,9%
Alteogen Inc 1,9%
Stryker Corp 1,89%
Samsung Biologics Co Ltd 1,86%
United Therapeutics Corp 1,84%
Samsung Biologics Co Ltd 1,84%
United Therapeutics Corp 1,84%
Resmed Inc 1,84%
Resmed Inc 1,83%
Penumbra Inc 1,83%
Globus Medical Inc 1,82%
Gsk Plc 1,82%
Penumbra Inc 1,82%
Gsk Plc 1,82%
Hoya Corp 1,81%
Hoya Corp 1,81%
Globus Medical Inc 1,8%
Astellas Pharma Inc 1,77%
Daiichi Sankyo Co Ltd 1,76%
Ucb Sa 1,76%
Astellas Pharma Inc 1,76%
Ucb Sa 1,71%
Daiichi Sankyo Co Ltd 1,7%
Universal Health Services Inc 1,69%
Sk Biopharmaceuticals Co Ltd 1,67%
Universal Health Services Inc 1,66%
Astrazeneca Plc 1,63%
Sk Biopharmaceuticals Co Ltd 1,62%
Ensign Group Inc/The 1,61%
Ensign Group Inc/The 1,59%
Astrazeneca Plc 1,59%
Shionogi & Co Ltd 1,56%
Shionogi & Co Ltd 1,55%
Intuitive Surgical Inc 1,51%
Intuitive Surgical Inc 1,48%
Insulet Corp 1,44%
Alnylam Pharmaceuticals Inc 1,38%
Chugai Pharmaceutical Co Ltd 1,38%
Chugai Pharmaceutical Co Ltd 1,37%
Boston Scientific Corp 1,35%
Alnylam Pharmaceuticals Inc 1,33%
Boston Scientific Corp 1,31%
Zoetis Inc 1,25%
Zoetis Inc 1,22%
Insulet Corp 1,15%
Alle anzeigen Verstecken
Andere - %

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.